Read news on mutant p53 with our app.
Read more in the app
MARK2: The “bodyguard” of mutant p53 in aggressive breast cancer - EurekAlert!
Breakthrough in cancer therapy: targeting mutant p53 with novel inhibitors shows promise - EurekAlert!
